QOL	Quality of life
STEPS	Stem cell therapies as an emerging paradigm in stroke
MSCs	Mesenchymal stem cells
NSCs	Neural stem cells
NPCs	Neural progenitor cells
MCAO	Middle cerebral artery occlusion
SVZ	Subventricular zone
SGZ	Subgranular zone
EE	Enriched environment
rTMS	Repetitive transcranial magnetic stimulation
tDCS	Transcranial direct current stimulation
rADSCs	Rat adipose-derived stem cells
hADMSCs	Human adipose-tissue-derived mesenchymal stem cells
hASCs	Human adipose stem cells
FGF-2	Fibroblast growth factor-2
VCAM-1	Vascular cell adhesion protein-1
MMP-2	Matrix metalloproteinase-2
ANGPT-1	Angiopoietin-1
ANGPT-2	Angiopoietin-2
hESC	Human embryonic stem cell
CS	Epidural cortical stimulation
NIBS	Noninvasive brain stimulation
BDNF	Brain-derived neurotrophic factor
MAPK	Mitogen-activated Protein Kinase
cAMP	Cyclic adenosine monophosphate
MAP-2	Microtubule-associated protein-2
GAP-43	Growth associated protein-43
SDF-1α	Stromal cell-derived factor-1α
MCPTs	Multicenter pre-clinical trials